Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entity

C2N Diagnostics

Tracked across 4 events · 28 articles · First seen Feb 19, 2026 · Last active Jul 04, 2026

Sentiment
35
Attention
6
Events
4
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 40
Tech
Impact: C2N Diagnostics developed PrecivityAD2, a clinically available Alzheimer's blood test used in the study, and is a startup co-founded by Washington University in St. Louis researchers.
Feb 19, 2026 · 6 articles
6 70
Tech
Impact: C2N Diagnostics is the manufacturer of the RealStar Filovirus Screen RT-PCR Kit 1.0, the first diagnostic test specifically authorized for emergency use against the Bundibugyo ebolavirus species, which has been added to the World Health Organization's Emergency Use Listing.
Jul 02, 2026 · 8 articles
3 30
Business
Impact: C2N Diagnostics was honored with the Axtria Bedrock Honor for a 15-year partnership with Axtria and the successful implementation of Axtria SalesIQ, demonstrating a complex sales force alignment solution.
Jun 25, 2026 · 8 articles
6 0
Tech
Apr 14, 2026 · 6 articles
ERGEN INTELLIGENCE
Track C2N Diagnostics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.